EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein 7 (IGFBP7) for the prediction of acute kidney injury following cardiac surgery

Yun Xie, Qin Guo, Bo Yang, Pan Xie, Jingxiao Zhang, Wei Lu, Claudio Ronco, Gengru Jiang

Cardiorenal Medicine · 2024

DOI: 10.1159/000538031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiorenal Medicine, 2024. Verfasst von Yun Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Xin Hua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China, xieyun@xinhuamed.com.cn. Hauptthemen laut MEDLINE: Acute Kidney Injury, Biomarkers, Cardiac Surgical Procedures, Insulin-Like Growth Factor Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cardiac surgery-associated acute kidney injury (CSA-AKI) is a common complication associated with increased morbidity and mortality. Tissue inhibitor metalloproteinases-2 • insulin-like growth factor-binding protein 7 (TIMP-2•IGFBP7) determines tubular stress markers, which may occur prior to tubular damage. Previous studies on the use of TIMP-2•IGFBP7 for the prediction of CSA-AKI showed divergent results. Therefore, this study aimed to explore the predictive value of TIMP-2•IGFBP7 measurements for the early detection of acute kidney injury (AKI) and short-term adverse outcomes after cardiac surgery.

Methods

In the prospective cohort study, blood and urine samples were collected 6–12 h after cardiac surgery. Blood samples to monitor serum creatinine levels were additionally extracted from days 1 to 7. AKI was defined based on the KDIGO consensus guidelines. AKI within 7 days following surgery was the primary outcome. The initiation of renal replacement therapy, in intensive care unit mortality, and the combination of both were secondary outcomes.

Results

A total of 557 patients were enrolled, 134 (24.06%) of them developed AKI and 33 (5.9%) had moderate or severe AKI. AKI developed more frequently in elderly patients with diabetes or with higher baseline serum creatinine levels. Patients with AKI had higher EuroSCORE II, Cleveland clinical score, and simplified renal index than those without AKI. Urinary TIMP-2•IGFBP7 was significantly higher in patients with AKI. The area under the curve was 0.66 in predicting all AKI and 0.70 in predicting stages 2 and 3 AKI. The resulting sensitivity and specificity were 44.0% and 83.9%, respectively, for a calculated threshold TIMP-2•IGFBP7 value of 0.265 (ng/ml)2/1,000. The TIMP-2•IGFBP7 values, simplified renal index (SRI) Score and age were significantly associated with AKI within 7 days postoperatively. A total of 33 patients reached the composite endpoint, the percentage of patients who reached the composite end-point in the TIMP-2•IGFBP7 of >0.265 (ng/ml)2/1,000 group was significantly higher than that of ≤0.265 (ng/ml)2/1,000 group.

Conclusions

Postoperative implementation of TIMP-2•IGFBP7 improved prediction of CSA-AKI and may aid in identifying patients at risk of short-term adverse outcomes. We identified an ideal calculated cutoff value of 0.265 (ng/ml))2/1,000 for the prediction of CSA-AKI among all AKI patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryBiomarkersCardiac Surgical ProceduresInsulin-Like Growth Factor Binding ProteinsTissue Inhibitor of Metalloproteinase-2FemaleHumansMaleCreatinineEarly DiagnosisPostoperative ComplicationsPredictive Value of TestsProspective Studies

Stichwörter der Autor:innen

Acute kidney injuryAdverse outcomesCardiac surgeryIGFBP7TIMP-2

Substanzen

BiomarkersCreatinineInsulin-Like Growth Factor Binding ProteinsTissue Inhibitor of Metalloproteinase-2insulin-like growth factor binding protein-related protein 1

Autor:innen und Institutionen

  • Department of Nephrology, Xin Hua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China, xieyun@xinhuamed.com.cn.
  • International Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, Vicenza, Italy, xieyun@xinhuamed.com.cn.
  • Department of Nephrology, Xin Hua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • International Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, Vicenza, Italy.
  • Department of Nephrology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Department of Nephrology, Southwest Hospital, First Affiliated Hospital to TMMU, Third Military Medical University (Army Medical University), Chongqing, China.

Zitieren

APA

Xie, Y., Guo, Q., Yang, B., Xie, P., Zhang, J., Lu, W., Ronco, C., & Jiang, G. (2024). Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein 7 (IGFBP7) for the prediction of acute kidney injury following cardiac surgery. Cardiorenal Medicine. https://doi.org/10.1159/000538031

Vancouver

Xie Y, Guo Q, Yang B, Xie P, Zhang J, Lu W, et al. Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein 7 (IGFBP7) for the prediction of acute kidney injury following cardiac surgery. Cardiorenal Medicine. 2024. doi:10.1159/000538031

BibTeX
@article{Xie2024,
  author = {Xie, Yun and Guo, Qin and Yang, Bo and Xie, Pan and Zhang, Jingxiao and Lu, Wei and Ronco, Claudio and Jiang, Gengru},
  title = {Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein 7 (IGFBP7) for the prediction of acute kidney injury following cardiac surgery},
  journal = {Cardiorenal Medicine},
  year = {2024},
  doi = {10.1159/000538031}
}
Kostenlos starten →